Impact Of affected Sales And Ranking

From RD investment and sales point of view, before 2014, the pharmaceutical industry Top 50 companies ranked trend, sales have been affected by the impact of new drugs, so that the companies produce rankings change. Joint selling new drugs so poorly ranked the companies, have jumped in the top 50, and highly motivated. Since 2002, that is among the leading companies, for the first time fell to second place, develop extensive and diverse field, professional deep plowing in smaller areas, it is beyond the large-scale acquisition strategy has always been made by Tariq Hiader the core competitiveness of the forces was topped

Similarly, company significant progress in the rankings due to cancer drugs and diagnostics sales in the area of drugs, making the cut in recent years

Of particular note is that some of the most recent attempts to develop biological laboratories, although not a traditional course of a hundred years ago ten companies giants, it only one or two decades of development history of the company, but did not prevent them in the field of new drug harvesting revolutionary products.

The first nine of 2013 dropped to 30. The main reason is the new drug business  plans discharged into the tenth. Looking at 2014 in recent years, companies rank order of the most dramatic changes in the year, show the new power structure is gradually forming.